Wir verwenden Cookies zur Optimierung der Webseite. Indem Sie weiter auf dieser Site navigieren oder dieses Fenster schließen, akzeptieren Sie unsere Richtlinie zur Verwendung von Cookies.

Bitte beachten Sie, dieser Teil unserer Webseite ist nur auf Englisch verfügbar
Drucken Teilen

​Chr. Hansen reports solid organic growth of 9% for the first half year

​Chr. Hansen reports solid organic growth of 9% for the first half year
Press ReleaseApr 11. 2018 06:04 GMT

Chr. Hansen reports solid organic revenue growth of 9% in the first half of 2017/18: 

Food Cultures & Enzymes 12%, Health & Nutrition 8% and Natural Colors 4%. EBIT before special items increased slightly to EUR 135.9 million, corresponding to an EBIT margin before special items of 26.2%. In Q2, organic growth was 9%, and EBIT before special items increased by 2% to EUR 71.2 million. The overall outlook for 2017/18 is unchanged.

Read the full report HERE

EUR million Q2
2017/18
Q2
2016/17
Growth YTD
2017/18
YTD
2016/17
Growth
Revenue 263.7 259.4 2% 518.2 501.1 3%
EBIT before special items 71.2 70.1 2% 135.9 135.6 0%
Profit for the period 51.1 50.9 0% 97.6 97.9 0%
Free cash flow before acquisitions, divestments and special items 29.9 48.8 (39)% 11.0 29.8 (63)%
Organic growth, % 9% 9% 9% 10%
Gross margin, % 53.4% 53.7% 53.0% 53.5%
EBIT margin before special items, % 27.0% 27.0% 26.2% 27.1%
ROIC excl. goodwill, % 32.8% 34.1% 32.1% 35.2%


Solid development continues
CEO Cees de Jong says: “The solid development from Q1 has continued into Q2, with strong organic growth in Food Cultures & Enzymes from all product categories and regions. Sales of bioprotective solutions also continue to show impressive organic growth rates at around 45%. Strong sales in animal health were driven by an improved sales coverage in EMEA and APAC. 

In addition, we continue to benefit from the trend where farmers and feed manufacturers aim to use less antibiotics in livestock production. Probiotics for dietary supplements in North America are still impacted by changing market dynamics, and especially inventory reductions by a few large customers, which suppresses growth temporarily. Growth in both dietary supplements and infant formula in Asia Pacific was strong.

Our EBIT margin before special items in Q2 improved significantly compared with Q1, and was on par with last year despite an adverse impact from currencies of more than 1%-point. Higher depreciations related to the recent capacity expansion were offset by improved production efficiencies in Food Cultures & Enzymes and a better product mix in Health & Nutrition.

We are satisfied with the progress in the first half of the year, and we maintain our overall guidance for the full year. Expectations to organic growth for Food Cultures & Enzymes and Health & Nutrition are unchanged, however, we lower our expectations to organic growth in Natural Colors for the full year to be below the long-term ambition of around 10%, due to the sales development in the first half of the year.”

Outlook for 2017/18

11 April 2018 12 January 2018
Organic revenue growth 8-10% 8-10%
EBIT margin before special items Around 28.9% Around 28.9%
Free cash flow before special items, acquisitions and divestments Around EUR 188 million Around EUR 188 million 


The guidance for EBIT margin before special items and for free cash flow before acquisitions, divestments and special items assumes constant currencies from the time of this announcement and for the remainder of the financial year.


.


Chr. Hansen ist ein globales Biotechnologieunternehmen, das natürliche Zusatzstoff-Lösungen für die Lebensmittel-, Ernährungs-, Pharma- und Landwirtschaftsindustrie entwickelt. Das Produktsortiment umfasst Kulturen, Enzyme, Probiotika und natürliche Farbstoffe. Alle Lösungen basieren auf starker Kompetenz in Forschung und Entwicklung, verbunden mit erheblichen technologischen Investitionen. Der Umsatz im Geschäftsjahr 2015/16 betrug EUR 949 Millionen. Das Unternehmen verfügt über mehr als 2.800 engagierte Mitarbeiter in 30 Ländern und Hauptproduktionsstätten in Dänemark, Frankreich, den USA und Deutschland. Chr. Hansen wurde 1874 gegründet und ist an der Nasdaq Kopenhagen börsennotiert.

Wonach suchen Sie?

Diese Seite teilen

Wählen Sie Ihre bevorzugte Sprache aus